Parkinson’s is a
neurodegenerative disease characterized by abnormal misfolded protein known as
alpha-synuclein. It is one of a group of disorders known as synucleinopathies. Accurate diagnosis of
any of these diseases, especially in the early stages, is challenging which can
result in misdiagnosis.
CND Life Sciences has developed
a new diagnostic tool called the Syn-One Test™ that accurately detects and
visualizes abnormal alpha-synuclein in cutaneous nerve fibers. The synucleinopathies encompass a
group of neurodegenerative diseases that include:
· Parkinson’s disease
· Dementia with Lewy bodies
· Multiple system atrophy
· Pure autonomic failure
· REM sleep behavior disorder
An abnormal test that identifies phosphorylated
synuclein (p-syn) within cutaneous nerves is highly specific for a diagnosis of
a synucleinopathy, but cannot distinguish between the synucleinopathies.
Physicians should use the results of the Syn-One Test along with other clinical
features to help make a more specific diagnosis.to help avoid
sub-optimal care recommendations and poor outcomes.
Personally, I want to know what I am dealing with
so I can seek appropriate treatment and make informed choices for my
future. While this is not an endorsement, it is a recommendation for
Movement disorder doctors, Palliative care teams, PwP’s, care partners and
their families to research this new development. For further
information, visit CND LIfe Sciences
- Home of the Syn-One Test™.
Kirk,
ReplyDeleteThank you! As we know first and foremost, we need an Impeccable diagnosis
Definitely agree!!
DeleteI was diagnosed with Parkinson’s four years ago, and medications weren’t helping as my symptoms worsened. Out of hope, I tried NaturePath Herbal Clinic’s program, and within months my tremors eased, balance improved, and energy returned. It’s been life-changing. I highly recommend their natural approach at www.naturepathherbalclinic.com
ReplyDelete